CASU, Gavino
 Distribuzione geografica
Continente #
NA - Nord America 4.237
AS - Asia 4.120
SA - Sud America 2.565
EU - Europa 1.452
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 12.541
Nazione #
US - Stati Uniti d'America 4.061
BR - Brasile 2.275
SG - Singapore 2.087
CN - Cina 669
IT - Italia 468
VN - Vietnam 394
HK - Hong Kong 372
DE - Germania 227
FR - Francia 200
AR - Argentina 101
UA - Ucraina 84
IN - India 79
GB - Regno Unito 76
CA - Canada 75
FI - Finlandia 75
RU - Federazione Russa 71
TR - Turchia 70
IQ - Iraq 64
BD - Bangladesh 61
MX - Messico 61
EC - Ecuador 54
UZ - Uzbekistan 47
ZA - Sudafrica 47
NL - Olanda 43
SE - Svezia 37
VE - Venezuela 37
JP - Giappone 36
AT - Austria 35
CO - Colombia 31
PK - Pakistan 30
KR - Corea 27
MA - Marocco 25
PL - Polonia 25
ID - Indonesia 23
KE - Kenya 22
CZ - Repubblica Ceca 19
ES - Italia 19
JO - Giordania 18
PE - Perù 18
PY - Paraguay 18
NP - Nepal 16
CL - Cile 15
KZ - Kazakistan 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
SA - Arabia Saudita 10
UY - Uruguay 10
LB - Libano 9
BE - Belgio 8
DO - Repubblica Dominicana 8
PH - Filippine 8
AL - Albania 7
IL - Israele 7
KG - Kirghizistan 7
MY - Malesia 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 7
JM - Giamaica 6
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
SN - Senegal 5
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
HN - Honduras 4
RO - Romania 4
RS - Serbia 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
GE - Georgia 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
TW - Taiwan 3
AM - Armenia 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
IE - Irlanda 2
IR - Iran 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
Totale 12.523
Città #
Dallas 1.967
Singapore 1.127
San Jose 641
Hong Kong 364
Ashburn 281
Beijing 234
São Paulo 171
Lauterbourg 148
Ho Chi Minh City 135
Shanghai 116
Hanoi 95
Santa Clara 84
Los Angeles 75
Munich 72
Chandler 67
Belo Horizonte 66
Rio de Janeiro 66
New York 56
Helsinki 45
Orem 44
Brasília 42
Curitiba 42
Nuremberg 42
Tashkent 41
Frankfurt am Main 37
Tokyo 34
Council Bluffs 33
Jacksonville 33
Porto Alegre 33
Rome 31
Boardman 27
Johannesburg 27
Milan 27
Campinas 26
Chennai 26
Romola 26
Tianjin 26
Baghdad 25
Sassari 25
Brooklyn 24
Da Nang 24
Montreal 24
Seoul 24
Princeton 22
Ribeirão Preto 22
Warsaw 21
Ann Arbor 20
Düsseldorf 20
Guayaquil 20
Nairobi 20
Salvador 20
Amsterdam 19
Boston 19
Denver 19
Wilmington 19
Guarulhos 18
Istanbul 18
Atlanta 17
Falkenstein 17
Quito 17
Vienna 17
Amman 16
Santo André 16
Stockholm 16
Toronto 16
Uberlândia 16
Belford Roxo 15
Dhaka 15
London 15
Sorocaba 15
Baku 14
Buenos Aires 14
Lima 14
Betim 13
Cagliari 13
Caracas 13
Dearborn 13
Juiz de Fora 13
Nanjing 13
Brno 12
Chicago 12
Gravataí 12
Mauá 12
São José dos Campos 12
Turku 12
Ankara 11
Aracaju 11
Canoas 11
Florence 11
Fortaleza 11
Goiânia 11
Houston 11
João Pessoa 11
Manaus 11
Mexico City 11
Mumbai 11
Poplar 11
Asunción 10
Biên Hòa 10
Bogotá 10
Totale 7.392
Nome #
Left atrial appendage occlusion: behind the bleeding risk 220
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 174
Left Atrial Appendage Closure vs. Oral Anticoagulation: still a matter of debate 170
Brain anticipatory cardiovascular responses to exercise 154
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 153
Permanent pacemaker dependency after transcatheter aortic valve implantation: Prevalence, patients’ characteristics, and main determinants 147
Aging of the Arterial System 136
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 134
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 131
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 130
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 129
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 126
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 125
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 113
Diagnosis of Brugada syndrome affects quality of life and psychological status 113
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 111
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 111
Integrating Pharmacological Features to Personalized Models With Statin Therapy 111
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 110
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 109
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 107
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 105
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 104
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 102
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 101
Serum albumin and mortality risk in old patients with acute ischemic stroke. 100
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 99
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 99
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: A webthal study 97
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 97
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 96
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 95
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 94
Abstract 110: Quality of life in Beta Thalassemia 93
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 92
Effect of rhTSH on Lipids 92
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 91
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 91
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 89
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 89
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 88
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 88
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 87
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension 87
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 86
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 86
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 85
Anomalous origin of right coronary artery from left sinus of valsalva 85
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 84
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 83
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 83
Letter to the editor 83
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 82
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 82
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 82
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 81
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 81
Correspondence 81
The experience of immersive virtual reality in patients with heart failure during cardiac rehabilitation: a qualitative study 81
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 80
Virtual reality and cardiac rehabilitation: a new middle-range theory to outline its mechanism of effectiveness 78
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 78
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 78
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 78
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 78
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 77
Does the age affect the outcomes of cardiac resynchronization therapy in elderly patients? 77
Vascular assisted-tracking for challenging transradial percutaneous intervention 77
Highly specialized stroke care improves the 30-day survival 77
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics 76
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 76
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 76
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 76
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment 74
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 74
Subsequent Event Risk in Individuals With Established Coronary Heart Disease 74
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 73
Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: Insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry 73
Impact of Selection Bias on Estimation of Subsequent Event Risk 73
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 72
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 72
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 71
Prevalence of the RR genotypes of the locus ACTN3-R577X in Italian Muay Thai elite fighters 71
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 70
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 70
Diuretic therapy in heart failure - Current approaches 69
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 69
The Italian registry of renal denervation 68
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 68
Effectiveness of virtual reality on pain and anxiety in patients undergoing cardiac procedures: A systematic review and meta-analysis of randomized controlled trials 68
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry 67
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 67
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study 66
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 66
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 66
Inside the “Razor Effect”: Lessons From Optical Coherence Tomography—What Does Angiography Hide? 66
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry 66
Brugada phenocopy in a patient with unstable angina and three-vessel coronary artery disease 65
The strategic alliance between clinical and molecular science in the war against sars-cov-2, with the rapid-diagnostics test as an indispensable weapon for front line doctors 65
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 65
Totale 9.185
Categoria #
all - tutte 45.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 15 6 2
2021/202247 9 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20254.896 16 91 292 132 172 200 258 856 1.786 730 211 152
2025/20266.937 322 1.662 752 1.077 808 361 1.044 193 355 363 0 0
Totale 12.765